Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Angela Rajek"'
Autor:
Stefaan Bouchez, Matti Kivikko, Fabio Guarracino, Piero Pollesello, Angela Rajek, Matthias Heringlake, Vladimir V. Lomivorotov, Bernard Cholley, Dominique Bettex
Publikováno v:
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
Journal of Cardiovascular Pharmacology
Journal of Cardiovascular Pharmacology
Levosimendan is a calcium sensitizer and ATP-dependent potassium channel opener which exerts sustained hemodynamic, symptomatic and organ-protective effects. It is registered for the treatment of acute heart failure, and when inotropic support is con
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bac79205967221c87c2a700353f5aed9
https://www.zora.uzh.ch/id/eprint/142247/
https://www.zora.uzh.ch/id/eprint/142247/
Autor:
Barbara Steinlechner, Michael Hiesmayr, Thomas Schlöglhofer, Nikolaus Heinrich, Angela Rajek, Daniel Zimpfer, Martin Dworschak, A. Schiferer
Publikováno v:
Medizinische Klinik - Intensivmedizin und Notfallmedizin. 110:421-430
Apart from heart transplantation, implantation of a left ventricular assist device (LVAD) is the only established surgical treatment for therapy-refractory terminal left heart failure, The specific intensive care unit (ICU) management of these patien
Autor:
Julia Riebandt, R. Moayedifar, Angela Rajek, Daniel Zimpfer, Andreas Zuckermann, Kamen Dimitrov, Philipp Angleitner, Guenther Laufer, A. Aliabadi-Zuckermann, T. Schloeglhofer
Publikováno v:
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 54(6)
Objectives Fixed pulmonary hypertension (fPH) is a contraindication for heart transplantation (HTX). Left ventricular assist device (LVAD) implantation as a bridge to candidacy can reverse fPH in patients with terminal heart failure by chronic left v
Autor:
Thomas Haberl, Julia Riebandt, Heinrich Schima, Stephane Mahr, Guenther Laufer, Angela Rajek, Barbara Steinlechner, Daniel Zimpfer
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 46:486-492
OBJECTIVES: Interagency Registry for Mechanical Assisted Circulatory Support (INTERMACS) Level I patients have the highest early mortality after ventricular assist device (VAD) implantation. This is determined by the exposure of patients in shock wit
Autor:
Angela Rajek, Daniel Zimpfer, Heinrich Schima, Thomas Haberl, Guenther Laufer, Julia Riebandt, Stephane Mahr, G.M. Wieselthaler, Sigrid Sandner
Publikováno v:
The Journal of Heart and Lung Transplantation. 33:88-93
Background Anti-coagulation is required in patients with left ventricular assist devices (LVADs). We evaluated the feasibility of low-molecular-weight heparin (LMWH) for initiation of anti-coagulation and transitioning to oral anti-coagulation after
Autor:
Thomas Haberl, Heinrich Schima, Angela Rajek, Stephane Mahr, Julia Riebandt, Guenther Laufer, Daniel Zimpfer
Publikováno v:
The Annals of Thoracic Surgery. 97:2214-2216
A novel, off-pump implantation technique for the HeartWare ventricular assist device with outflow graft anastomosis to the left subclavican artery is described. Cannulation of the left ventricular apex is performed through an incision in the left fou
Autor:
Daniel Zimpfer, R. Moayedifar, G. Laufer, Julia Riebandt, Thomas Schlöglhofer, Kamen Dimitrov, Dominik Wiedemann, Angela Rajek
Publikováno v:
The Journal of Heart and Lung Transplantation. 37:S480
Autor:
Georg Wieselthaler, Heinrich Schima, Ernst Wolner, Philipp Zrunek, Daniel Zimpfer, Sigrid Sandner, Angela Rajek, Barbara Steinlechner
Publikováno v:
Artificial Organs. 32:819-822
We present a regimen for anticoagulation in the immediate postoperative period after left ventricular assist device (LVAD) implantation using low molecular weight heparin (LMWH) as an alternative to unfractionated heparin. Between May and September 2
Autor:
Ernst Wolner, Angela Rajek, Michael Grimm, Daniela Dunkler, Georg Wieselthaler, Ulrike Salzer-Muhar, Martin Hülsmann, Axel Laczkovics, Stephane Mahr, Günther Laufer, Arezu Aliabadi, Brigitte Bunzel, Richard Pacher, Daniel Zimpfer, Gregor Wollenek, Martina Grömmer, Andreas Zuckermann, Günter Weigel
Publikováno v:
Wiener klinische Wochenschrift. 120:3-10
Since the beginning of the University of Vienna Cardiac Transplant Program in 1984, 1113 heart transplant procedures have been performed through August of 2008. One- and five-year survival has increased steadily over time (82% and 76%). Ten-year surv
Autor:
Andrea Moritz, Beatrice Birkenberg, B. Mora, A. Schiferer, Angela Rajek, Thomas Lang, Barbara Steinlechner, Martin Dworschak
Publikováno v:
British Journal of Anaesthesia. 98:598-603
High-dose remifentanil (1-5 microg kg-1 min-1), commonly used for cardiac surgery, has been associated with muscle rigidity, hypotension, bradycardia, and reduced cardiac output. The aim of this study was to determine an optimal lower remifentanil do